She oversees the day-to-day work of the Center’s Project on Precision Medicine, Artificial Intelligence, and the Law (PMAIL), including conducting law, policy, and ethics research; drafting reports and recommendations; and coordinating the Center’s efforts with collaborators at the Center for Advanced Studies in Biomedical Innovation Law (CeBIL) at the University of Copenhagen as well as other partners.
Sara’s current research focuses on the ethical and legal challenges of artificial intelligence and big data in the United States and Europe. Sara also researches comparative law and ethics of other digital health topics such as ingestible electronic sensors (“smart pills”) as well as mitochondrial replacement techniques.
Sara’s work has appeared in venues such as JAMA, Science, Nature Medicine, npj Digital Medicine, Nature Electronics,Nature Biotechnology, The Lancet Digital Health, Annual Reviews of Genomics and Human Genetics, Journal of Law and the Biosciences, Elsevier, Springer and Hastings Center Report.
Before joining the Petrie-Flom Center, Sara was the General Manager of the Institute for German, European and International Medical Law, Public Health Law and Bioethics of the Universities of Heidelberg and Mannheim (IMGB) in Germany. She was also the Co‑Investigator of an interdisciplinary project, known as “ClinhiPS”, sponsored by the German Federal Ministry of Education and Research (funds: 657,678.00 EUR; term: April 2016 to March 2018). This project analyzed the clinical application of human induced pluripotent stem cells (hiPSCs) in Germany and Austria from scientific, ethical, and comparative legal perspectives.